Archives

Perfusfind S.L.

El tratamiento con CytoSorb se aplicó de forma prospectiva y se analizó de forma retrospectiva en el grupo de control, en los pacientes con sepsis de orígen pulmonar y SDRA..

Perfusfind S.L.

Actualmente se dispone de opciones de tratamiento limitadas para pacientes graves de COVID-19 en UCI, pudiendo alcanzar tasas de mortalidad de hasta el 50 %.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/cytosorb-covid19_compressed.pdf" title="cytosorb covid19_compressed"]  

Perfusfind S.L.

This case reports on a 6-year-old, previously healthy girl who presented to the hospital with a febrile illness and profound pain in her lower extremities.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Cytosorb-for-Management-of-Acute-Kidney-Injury-due-to-Rhabdomyolysis-in-a-Child_compressed.pdf" title="Cytosorb for..

Perfusfind S.L.

This case reports on a 58-year-old male was hospitalized with a 2-day history of chest pain and dyspnea on exertion (New York Heart Association Class III).   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-in-the-management-of-severe-septic-shock-after-coronary-artery-bypass-graft-surgery_compressed.pdf" title="CytoSorb..

Perfusfind S.L.

CytoSorb Therapy was prospectively applied and retrospectively analyzed to the control group, in patients with pneumogenic sepsis and ARDS until shock reversal was achieved   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy-enhanced-ECMO_compressed.pdf" title="CytoSorb Therapy enhanced..

Perfusfind S.L.

Limited treatment options are currently available for critically-ill COVID-19 ICU patients who may experience mortality rates up to 50%.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy-Manage-cytokine-storm-in-patients-with-COVID-19_compressed.pdf" title="CytoSorb Therapy Manage cytokine storm in patients with..

Perfusfind S.L.

In these patients there is a high chance of success (shock reversal) possibly translating to survival benefits when the adsorber treatment is started in good time.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy_compressed.pdf" title="CytoSorb..

Perfusfind S.L.

This case reports on a 49-year-old previously healthy female patient, who presented to the Accident and Emergency Department of a peripheral hospital with complaints of breathlessness and fever for one..

Perfusfind S.L.

The following case study reports on a 13-year-old pediatric patient (body weight 45 kg) who was admitted to our hospital due to a deterioration in his clinical condition, after he..

Perfusfind S.L.

This case study reports on a 69-year-old female patient (pre-existing medical conditions: chronic heart failure NYHA III, Type 2 diabetes mellitus, multiple myeloma, chronic kidney disease stage 3), who was..

Perfusfind S.L.

El ticagrelor es un inhibidor de la agregación plaquetaria y se recomienda en las directrices europeas para el tratamiento del síndrome coronario agudo y para la profilaxis de la trombosis..

Perfusfind S.L.

Ticagrelor is a platelet aggregation inhibitor and is recommended in the current European Guidelines for the treatment of acute coronary syndrome and prevention of stent thrombosis.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Reduce-bleeding-complications-in-patients-on-ticagrelor_compressed.pdf" title="Reduce..

Perfusfind S.L.

The intraoperative use of the CytoSorb hemoadsorption in patients with ticagrelor or rivaroxaban treatment undergoing emergency open-heart operations is a safe and effective method to reduce bleeding complications and to..

Perfusfind S.L.

Con el uso de Cytosorb los datos clínicos actuales apuntan claramente a una estabilización rápida de la hemodinamia y las funciones orgánicas de los pacientes de cuidados intensivos con síndrome..

Perfusfind S.L.

El uso intraoperatorio de CytoSorb en pacientes sometidos a tratamiento con ticagrelor o rivaroxaban que tienen que someterse a una cirugía de emergencia a corazón abierto es un método seguro..

Perfusfind S.L.

This case reports on a 23-year-old male patient, who was admitted to the hospital with complaints of dyspnea associated with tiredness, dizziness and chest discomfort.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-undergoing-orthotopic-heart-transplant-surgery-_compressed.pdf" title="Use of..

Perfusfind S.L.

This case reports on a 58-year-old male patient who was admitted to the South Munich Surgical Clinic for urgent coronary artery bypass surgery.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Ticagrelor-and-Rivaroxaban-Elimination-With-CytoSorb-Adsorber-Before-Urgent-Off-Pump-Coronary-Bypass-_compressed.pdf" title="Ticagrelor and Rivaroxaban Elimination..

Perfusfind S.L.

This case study reports on a 59-year-old patient who presented with dyspnea and weight gain of 12 kg at a peripheral hospital.    [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-mitral-valve-dysfunction-atypical-pneumonia-and-mixed-cardiogenic-and-septic-shock_compressed.pdf" title="Use of CytoSorb in a..

Perfusfind S.L.

This case reports on a 76-year-old male patient, who was admitted to the emergency department two weeks after an elective and initially complication-free pancreas resection with acute abdomen, signs of..

Perfusfind S.L.

This case reports on a 2-year-old male patient (weight 12 kg), who was admitted to the children‘s outpatient department with anuria, bloody diarrhea, anemia and severe edema (anasarca).   [pdf-embedder..

Perfusfind S.L.

This case reports on a 79-year-old female patient who presented to the hospital for elective surgery due to severe mitral valve and tricuspid valve insufficiency.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-severe-ARDS-and-septic-shock-after-mitral-valve-and-tricuspid-valve-reconstruction_compressed.pdf" title="Use of..

Perfusfind S.L.

This case reports on a 31-year-old male patient with no significant medical history, who was hospitalized following several days of non-quantified fever associated with odynophagia.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-severe-COVID-19_compressed.pdf" title="Use of..

Perfusfind S.L.

This report describes the case of a 59-year-old patient who was transferred from a peripheral hospital for emergency surgery for a type A aortic dissection with paraparesis of the legs,..

Perfusfind S.L.

The case study reports on a 16-year-old girl, who presented to the hospital with syncope and fever (39°C), tachycardia, complaints of chest pain and coughing after fainting at home.  ..

Perfusfind S.L.

This case reports on a 13-year-old male patient who presented to hospital with fever (38.9°), reduced general condition, vomiting and pain in his limbs.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-pediatric-patient-with-severe-rhabdomyolysis-in-the-context-of-a-SARS-CoV-2-infection_compressed.pdf" title="Use of CytoSorb..

Perfusfind S.L.

This case reports on a 48-year-old male patient who was transferred by air ambulance from a Caribbean island to Hospital Pacifica Salud in Panama due to a stroke, altered consciousness,..

Perfusfind S.L.

This case reports on a 7-month-old male pediatric patient (known pre-existing conditions: trisomy 21 (also known as Downs syndrome), aortic isthmus stenosis, atrioventricular septal defect (AVSD) Rastelli type C), who..

Perfusfind S.L.

This case study reports on a 58-year-old female patient (known pre-existing conditions: very severe COPD (Gold stage IV), encapsulated pleural effusion with suspicion of empyema after left lung volume reduction..

Perfusfind S.L.

This case study reports on a 56-year-old female patient who presented at the Cardiac Center Aarau for elective mitral valve reconstruction/replacement and left atrial appendage occlusion, after she suffered cardiac..

Perfusfind S.L.

CEC con CytoSorb - Uso intraoperatorio Preparar por completo la máquina cardiopulmonar según las instrucciones de uso del fabricante (incluyendo el cebado). [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CEC-con-CytoSorb-Uso-intraoperatorio-Guía-rápida-de-configuración_compressed.pdf" title="CEC con CytoSorb – Uso intraoperatorio..